CD68 and neoplasm: A significant increase in tumor infiltrating myeloid populations, namely CD68+ macrophages and CD11b+ cells, both in the tumor bulk and in the infiltrative regions, was also observed in autopsy brain specimens of rGBM patients treated with anti-angiogenic therapy; of note, an increased number of tumor infiltrating CD11b+ cells proved to correlate with decreased OS in these patients [57].